Interstitial pneumonias

Dail and Hammar's Pulmonary Pathology

Volumn 1, Issue , 2008, Pages 695-721

  Nicholson, Andrew G ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890171371     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68792-6_19     Document Type: Chapter

References (163)

1. Turner-Warwick M. Interstitial lung disease. Sem Respir Med 1984;6:1-102.
2. Hamman L, Rich A. Acute diffuse interstitial fibrosis of the lung. Bull Johns Hopkins Hosp 1944;74:177.
3. Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, Lemay E, eds. Frontiers in pulmonary radiology. New York: Grune and Stratton, 1969: 102-141.
4. Scadding JG. Fibrosing alveolitis. Br Med J 1964;2:686.
5. Scadding JG, Hinson KFW. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967;22: 291-304.
6. Anttila S, Sutinen S, Paananen M et al. Hard metal lung disease: a clinical, histological, ultrastructural and X-ray microanalytical study. Eur J Respir Dis 1986;69;83-94.
7. Demedts M, Gheysens B, Nagels J, et al. Cobalt lung in diamond polishers. Am Rev Respir Dis 1984;130:130-135.
8. Myers JL, Veal CF Jr, Shin MS, Katzenstein AL. Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987; 135;880-884.
9. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64:1373-1380.
10. Katzenstein AA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-147.
11. Katzenstein A-L, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Patho 11986;10(4):256-267.
12. Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-1315.
13. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
14. Nicholson AG, Colby TV, du Bois RM, Hansell DM, Wells AU. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 2000;162:2213-2217.
15. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203.
16. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905.
17. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010-1019.
18. Travis WD, Matsui K, Moss J, Ferrans VI Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns-survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19-33.
19. Flaherty KR, Travis WD, Colby TV, et al. Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias. Am J Respir Crit Care Med 2001;164:1722-1727.
20. Flaherty KR, Toews GB, Travis WD, et al. Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 2002;19:275-283.
21. Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999;211:555-560.
22. Tung KT, Wells AU, Rubens MB, Kirk JM, du BR, Hansell DM.Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993;48:334-338.
23. Hansell DM, Wells AU. CT evaluation of fibrosing alveolitis-applications and insights. J Thoracic Imag 1996;11: 231-249.
24. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
25. Johnston ID, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax 1997;52:38-44.
26. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164: 193-196.
27. Myers JL. NSIp, VIp, and the ABCs of idiopathic interstitial pneumonias. Eur Respir J 1998;12:1003-1004.
28. Primack SL, Hartman TE, Hansell DM, Muller NL. Endstage lung disease: CT findings in 61 patients. Radiology 1993;189:681-686.
29. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-809.
30. Katzenstein AL, Myers JL, Prophet WD, Corley LS, Shin MS. Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986;10:373-381.
31. Katzenstein A-LA, Askin FE. Idiopathic interstitial pneumonia. In: Katzenstein A-LA, Askin FB, eds. Surgical pathology of non-neoplastic lung disease. Philadelphia: WB Saunders, 1997:4880.
32. King TE Jr, Schwarz MI, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001;164: 1025-1032.
33. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU. The frequency of fibroblastic foci in usual interstitial pneumonia and their relationship to disease progression. Am J Respir Crit Care Med 2002;166:173-177.
34. Britton J, Hubbard R. Recent advances in the aetiology of cryptogenic fibrosing alveolitis. Histopathology 2000;37: 387-392.
35. Yousem SA Eosinophilic pneumonia-like areas in idiopathic usual interstitial pneumonia. Modem Pathol 2000; 13: 1280-1284.
36. Stack BH, Choo-Kang YF, Heard BE. The prognosis of cryptogenic fibrosing alveoli tis. Thorax 1972;27:535-542.
37. Turner-Warwick M, Burrows B, Johnson A Cryptogenic fibrosing alveoli tis: clinical features and their influence on survival. Thorax 1980;35:171-180.
38. Turner-Warwick M, Burrows B, Johnson A Cryptogenic fibrosing alveoli tis: response to corticosteroid treatment and its effect on survival. Thorax 1980;35:593-599.
39. Tukiainen P, Taskinen E, Holsti P, Korhola 0, Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983;38:349-355.
40. Hubbard R, Johnston I, Britton J. Survival in patients with cryptogenic fibrosing alveoli tis: a population-based cohort study. Chest 1998;113:396-400.
41. Johnston IDA, Prescott RJ, Chalmers JC, Rudd RM. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997;52:38-44.
42. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-1181.
43. Marshall RP, Puddicombe A, Cookson WOC, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000;55:143-146.
44. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveoli tis. Am Rev Respir Dis 1987;135:26-34.
45. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999;14:245-248.
46. Haslam PL, Turton CW, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveo-litis and their relation to therapy. Thorax 1980;35: 328-339.
47. Veeraraghavan S, Latsi PI, Wells AU, et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J 2003;22:239-244.
48. Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveoli tis compared with the fibrosing alveoli tis of systemic sclerosis. Am J Respir Crit Care Med 1998;157:1474-1482.
49. Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH. A preliminary study of long-term treatment with interferon gamma-1 b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999;341: 1264-1269.
50. Nathan SD, Barnett SD, Moran B, et al. Interferon gamma-1 b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis. Respiration 2004;71:77-82.
51. Raghu G, Brown KK, Bradford WZ, et al. A placebocontrolled trial of interferon gamma-1 b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350: 125-133.
52. Meyer A, Buhl R, Kampf S, Magnussen H. Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals. Am J Respir Crit Care Med 1995;152:1055-1060.
53. MacNee W, Rahman I. Oxidants/antioxidants in idiopathic pulmonary fibrosis. Thorax 1995;50(suppl 1):S53-S58.
54. Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch Jp, III. Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004;64:405-430.
55. Thannickal VJ, Toews GB, White ES, Lynch JP III, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395-417.
56. Turner-Warwick M, Lebowitz M, Burrows B, Johnson A Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980;35:496-499.
57. Kumar P, Goldstraw P, Yamada K, et al. Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003;125:1321-1327.
58. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003;167:962-969.
59. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:510-511.
60. Wangoo A, Shaw RJ, Diss TC, Farrell PJ, duBois RM, Nicholson AG. Cryptogenic fibrosing alveoli tis: lack of association with Epstein-Barr virus infection. Thorax 1997;52: 888-891.
61. Tsukamoto K, Hayakawa H, Sato A, Chid a K, Nakamura H, Miura K. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 2000;55:958-961.
62. Stewart JP, Egan JJ, Ross AJ et al. The detection of EpsteinBarr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999;159:1336-1341.
63. Meliconi R, Andreone P, Fasano L et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996;51:315-317.
64. Hubbard R. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. Eur Respir J Suppl 2001;32:119s-121s.
65. Tobin RW, Pope CE, Pellegrini CA, Emond MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804-1808.
66. Hubbard R, Venn A, Smith C, Cooper M, Johnston I, Britton 1. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: A case-control study. Am J Respir Crit Care Med 1998;157:743-747.
67. Hubbard R, Venn A, Britton 1. Exposure to antidepressants and the risk of cryptogenic fibrosing alveolitis: a casecontrol study. Eur Respir J 2000;16:409-413.
68. Wallace WAH, Howie SEM. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease. J Pathol 1999;187:475-480.
69. Whyte M, Hubbard R, Meliconi R, et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000;162:755-758.
70. Pantelidis P, Fanning GC, Wells AU, Welsh KI, du Bois RM. Analysis of tumor necrosis factor-alpha, lymphotoxinalpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;163:1432-1436.
71. Thomas AQ, Lane K, Phillips JIll, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-1328.
72. Kradin RL, Divertie MB, Colvin RB, et al. Usual interstitial pneumonitis is a T-cell alveolitis. Clin Immunol Immunopathol 1986;40:224-235.
73. Wells AU, Lorimer S, Majumdar S, et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 1995;8:266-271.
74. Wallace WA, Schofield JA, Lamb D, Howie SE. Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994;49:1139-1145.
75. Jakubzick C, Choi ES, Carpenter KJ, et al. Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol 2004;164:1989-2001.
76. Keane MP, Arenberg DA, Lynch JP III, et al. The CXC chemokines, IL-8 and IP-lO, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159: 1437-1443.
77. Lappi-Blanco E, Soini Y, Kinnula V, Paakko P. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol 2002;196:220-227.
78. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokersand patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002;166:382-385.
79. Lappi-Blanco E, Kaarteenaho-Wiik R, Soini Y, Risteli J, Paakko P. Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized. Hum Pathol 1999;30:1192-1196.
80. Ebina M, Shimizukawa M, Shibata N, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004;169: 1203-1208.
81. Renzoni EA. Neovascularization in idiopathic pulmonary fibrosis: too much or too little? Am J Respir Crit Care Med 2004;169:1179-1180.
82. Nicholson AG, Gibbs AR, Addis BJ, et al. Interobserver variation in diffuse parenchymal lung disease. Thorax 2004;59:500-505.
83. Monaghan H, Wells AU, Colby TV, du Bois RM, Hansell DM, Nicholson AG. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004;125: 522-526.
84. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003;58:143-148.
85. Ognibene FP, Masur H, Rogers P, et al. Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). Ann Intern Med 1988;109: 874-879.
86. MacDonald SL, Rubens MB, Hansell DM, et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001;221:600-605.
87. Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: Variable appearance at high-resolution chest CT. Radiology 2000;217:701-705.
88. Akira M, Inoue G, Yamamoto S, Sakatani M. Non-specific interstitial pneumonia: findings on sequential CT scans of nine patients. Thorax 2000;55:854-859.
89. Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JE Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286-1293.
90. Nicholson AG, Wells AU. Nonspecific interstitial pneumonia-nobody said it's perfect. Am J Respir Crit Care Med 2001;164:1553-1554.
91. Hansell DM, Nicholson AG. Smoking related diffuse parenchymal lung disease: HRCT-pathologic correlation. Sem Respir Crit Care Med 2003;24:377-392.
92. Bouros D, Nicholson AG, Colby TV, et al. Histopathological subsets of fibrosing alveolitis in patients with scleroderma and their relationship to natural history and treated course. Am J Respir Crit Care Med 2002;165:1581-1586.
93. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-1185.
94. Tansey D, Wells AU, Colby TV, et al. Variations in histologic patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-596.
95. Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic and pathologic study. Am J Respir Crit Care Med 2005;171: 632-638.
96. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974;291:755-758.
97. Moon J, du Bois RM, Colby TV, Hansell DM, Nicholson AG. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999;54:1009-1014.
98. Fraig M, Shreesha U, Savici D, Katzenstein AL. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002;26:647-653.
99. King TE. Respiratory bronchiolitis-associated interstitial lung disease. Clin Chest Med. 1993;14:693-698.
100. Park JS, Brown KK, Tuder RM, Hale VA, King Jr.TE, Lynch DA Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 2002;26:13-20.
101. Heyneman LE, Ward S, Lynch DA, RemyJardin M, Johkoh T, Muller NL. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: Different entities or part of the spectrum of the same disease process? Am J Roentgenol 1999;173:1617-1622.
102. Agius RM, Rutman A, Knight RK, Cole PI Human pulmonary alveolar macrophages with smokers' inclusions: their relation to the cessation of cigarette smoking. Br J Exp Pathol 1986;67:407-413.
103. Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, Sobaszek A Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 2002;222:261-270.
104. Fromm GB, Dunn LJ, Harris JO. Desquamative interstitial pneumonitis. Characterization of free intraalveolar cells. Chest 1980;77:552-554.
105. Hartman TE, Primack SL, Kang EY, et al. Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest 1996;110:378-382.
106. Akira M, Yamamoto S, Hara H, Sakatani M, Ueda E. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997;52:333-337.
107. Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004;45:275-282.
108. Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G, Muller NL. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187: 787-790.
109. Kubo M, Koshino T, Shimizu H, et al. A case of desquamative interstitial pneumonia with increased numbers of eosinophils in the bronchoalveolar lavage fluid. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:1084-1092.
110. Matsuo K, Tada S, Kataoka M et al. Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997;36:728-731.
111. Kitaichi M. Desquamative interstitial pneumonia: an idiopathic interstitial pneumonia with a possibility of spontaneous regression. Intern Med 1997;36:672-673.
112. Stillwell P, Norris DG, 0 'Connell EJ, Rosenow EC, Weiland LH, Harrison EG. Desquamative interstitial pneumonitis in children. Chest 1980;77:165-171.
113. Tal A, Maor E, Bar-Ziv J, Gorodischer R. Fatal desquamative interstitial pneumonia in three infants siblings. J Pediatr 1984;104:873-876.
114. Herbert A, Sterling G, Abraham J, Corrin B. Desquamative interstitial pneumonia in an aluminum welder. Hum Pathol 1982;13:694-699.
115. Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J PathoI1985;147:107-119.
116. Freed JA, Miller A, Gordon RE, Fischbein A, Kleinerman J, Langer AM. Desquamative interstitial pneumonia associated with chrysotile asbestos fibres. Br J Ind Med 1991;48:332-337.
117. Hamadeh MA,Atkinson J, Smith LI Sulfasalazine-induced pulmonary disease. Chest 1992;101:1033-1037.
118. Amir G, Ron N. Pulmonary pathology in Gaucher's disease. Hum Pathol 1999;30:666-670.
119. Aubry MC,WrightJL,MyersJL.The pathology of smokingrelated lung diseases. Clin Chest Med 2000;21:11-35, vu.
120. Nagai S, Hoshino Y, Hayashi M, Ito 1. Smoking-related interstitial lung diseases. Curr Opin Pulmon Med 2000;6: 415-419.
121. Ryu JH, Colby TV, Hartman TE, Vassallo R. Smokingrelated interstitial lung diseases: a concise review. Eur Respir J 2001;17:122-132.
122. Selman M. The spectrum of smoking-related interstitial lung disorders: the never-ending story of smoke and disease. Chest 2003;124:1185-1187.
123. Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003;124:1199-1205.
124. Rice AJ, Wells AU, Bouros D, et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study. Am J Clin Pathol 2003;119:709-714.
125. Olson J, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990;65:1538-1548.
126. Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993;103:1808-1812.
127. Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 1997;168:79-83.
128. Kitaichi M. Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto University 1990;23:1-18.
129. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J 2003;22:821-826.
130. Vourlekis JS, Brown KK, Cool CD et al. Acute interstitial pneumonitis-case series and review of the literature. Medicine 2000;79:369-378.
131. Ichikado K, Suga M, Muller NL, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 2002;165:1551-1556.
132. Suga T, Sugiyama Y, Ohno S, Kitamura S. Two cases of lIP which developed acute exacerbation after bronchoalveolar lavage. Nihon Kyobu Shikkan Gakkai Zasshi 1994;32:174-178.
133. Enomoto T, Kawamoto M, Kunugi S, et al. Clinicopathological analysis of patients with idiopathic pulmonary fibrosis which became acutely exacerbated after videoassisted thoracoscopic surgical lung biopsy. Nihon Kokyuki Gakkai Zasshi 2002;40:806-811.
134. Colby TV. Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992;102:38S-43S.
135. Myers JL, Colby TV. Pathologic manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse pan bronchiolitis. Clin Chest Med 1993;14:611-622.
136. DavisonAG, Heard BE, McCallister WAC, Turner-Warwick MEH. Cryptogenic organising pneumonitis. Q J Med 1983;52:383-394.
137. King TEJ, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102: 8S-13S.
138. Cordier JP. Organising pneumonia. Thorax 2000;55:318-328.
139. Kramer MR, Saldana MJ, Ramos M, Pitchenik AE. High titres of Epstein-Barr virus antibodies in adult patients with lymphocytic interstitial pneumonitis associated with AIDS. Respir Med 1992;86:49-52.
140. Barbera JA, Hayashi S, Hegele RG, Hogg Je. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridisation. Am Rev Respir Dis 1992;145: 940-946.
141. Kaan PM, Hegele RG, Hayashi S, Hogg Je. Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia. Thorax 1997;52:12-16.
142. Andiman WA, Eastman R, Martin K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985;2: 1390-1393.
143. Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 1987;19:178-185.
144. Strimlan CV, Rosenow EC, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978;88:616-621.
145. Nicholson AG, Wotherspoon AC, Diss TC, et al. Reactive pulmonary lymphoid disorders. Histopathology 1995;26: 405-412.
146. Yousem SA, Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod PathoI2002;15:1148-1153.
147. Churg A, Myers J, Suarez T, et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am J Surg Pathol 2004;28:62-68.
148. Fukouka J, Franks TJ, Colby TV, et al. Peri bronchiolar metaplasia (PBM): a common incidental histologic lesion and a rare cause of interstitial lung disease (PBM-ILD). Mod Pathol 2004;17:336A.
149. Fan LL. Chronic interstitial lung disease in children. Pediatr Pulmonol 1993,16:184-196
150. Bokulic RE, Hilman Be. Interstitial lung disease in children. Pediatr Clin North Am 1994;41(3):543-567.
151. Katzenstein A-LA, Gordon LP, Oliphant M, Swender PT. Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 1995;19(4):439-447.
152. Schroeder SA, Shannon DC, Mark EJ. Cellular interstitial pneumonitis in infants: a clinicopathologic study. Chest 1992; 101:1065-1069.
153. Bush A, du Bois RM. Congenital and pediatric interstitial disease. Curr Opin Pulmonol Med 1996;2:347-356.
154. Bush A. Diagnosis of interstitial lung disease. Pediatr PulmonoI1996;22: 81-82.
155. Fan LL. Evaluation and therapy of chronic interstitial pneumonitis in children. Curr Opin Pediatr. 1994 6: 248-254
156. Clement A, Allen J, Corrin B, et al. Task force on chronic interstitial lung disease in immunocompetent children. Eur Respir J 2004;24:686-697.
157. Nicholson AG, Kim H, Corrin B, et al. The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology 1998;33: 203-211.
158. Katzenstein A-L, Askin FB. Pediatric disorders. In: Katzenstein M, Askin FB, eds. Surgical pathology of nonneoplastic lung disease. Philadelphia: WB Saunders, 1997: 361-382.
159. Fan LL., Pediatric interstitial lung disease. In: Schwartz MI, King TE Jr, eds. Interstitial lung disease, Hamilton: Decker, 1998, 103-188.
160. Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344(8):573-579.
161. Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol 2004;66: 601-623.
162. Waters KA, Bale P, Isaacs D, Mellis e. Successful chloroquine therapy in a child with lymphoid interstitial pneumonitis. J Pediatr 1991;119:989-991.
163. Sharief N, Crawford OF, Dinwiddie R. Fibrosing alveoli tis and desquamative interstitial pneumonitis. Pediatr Pulmonol 1994;17:359-365.